Clinical Trial Update: HF Patients With LVADs Being Treated With SGLT2i [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on heart failure patients with left ventricular assist devices treated with SGLT2 inhibitors, now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: University of Chicago | Conditions: Heart Failure With Reduced Ejection Fraction | Phase 4 | Status: COMPLETED